Online Weight Loss Medication in Florida: 2026 Guide
Florida has over 22 million residents and an adult obesity rate of approximately 29%. Here is how Floridians can access GLP-1 medications through telehealth.
Medical Disclaimer: This article is for informational purposes only. Weight loss medications require a prescription from a licensed healthcare provider.
Florida's warm climate and active lifestyle culture make it a natural fit for weight loss treatment. With telehealth, Floridians from Miami to Jacksonville to Pensacola can access semaglutide and tirzepatide without leaving home.
Florida Telehealth Regulations
- Prescribing allowed: Florida-licensed providers can prescribe weight loss medications via telehealth after establishing a provider-patient relationship
- No in-person requirement: Initial consultations can be conducted entirely via telehealth
- Provider licensing: Providers must hold an active Florida medical license
- Pharmacy: Prescriptions can be filled by Florida-licensed pharmacies or out-of-state pharmacies licensed to ship to Florida
How to Get Started in Florida
- Choose a telehealth provider licensed in Florida (such as Trimi)
- Complete a medical intake questionnaire online
- Meet with a Florida-licensed clinician via video consultation
- Receive your prescription if medically appropriate
- Medication ships directly to your Florida address
Insurance Coverage in Florida
- Private insurance: Many Florida plans cover GLP-1 medications with prior authorization, especially employer-sponsored plans
- Florida Medicaid: Limited weight loss medication coverage. Primarily covers GLP-1 for diabetes
- Medicare (large FL senior population): Medicare Part D may cover Wegovy for cardiovascular risk reduction in eligible patients
- ACA Marketplace plans: Coverage varies by plan. Check your formulary for specific GLP-1 coverage
Cost Comparison
| Option | Monthly Cost | Notes |
|---|---|---|
| Brand Wegovy (cash) | $1,349+ | Retail pharmacy |
| Brand Zepbound (cash) | $1,059+ | Retail pharmacy |
| With insurance | $25-$150 | Varies by plan |
| Compounded (Trimi) | $$ | No insurance needed |
Florida Cities Served
Trimi serves patients throughout Florida via telehealth:
- Jacksonville, Miami, Tampa, Orlando, St. Petersburg
- Hialeah, Port St. Lucie, Cape Coral, Tallahassee, Fort Lauderdale
- Pembroke Pines, Hollywood, Gainesville, Miramar
- All other Florida cities and communities
Frequently Asked Questions
Can I get weight loss medication online in Florida?
Yes. Florida permits telehealth prescribing for weight loss medications. Florida-licensed providers can evaluate you via video consultation and prescribe GLP-1 medications. Trimi offers online consultations with Florida-licensed clinicians.
Does Florida Medicaid cover GLP-1 for weight loss?
Florida Medicaid has limited coverage for weight loss medications. GLP-1 coverage is primarily for diabetes indications. For weight loss, most Florida Medicaid patients find compounded options more affordable and accessible.
How much does weight loss medication cost in Florida?
Brand-name GLP-1 medications cost $900-$1,600 per month without insurance at Florida pharmacies. Compounded options through providers like Trimi cost significantly less, making treatment accessible for self-pay patients.
Do Florida telehealth laws require video visits?
Florida allows both video and audio-only telehealth visits for many services. However, most weight loss providers prefer video consultations for initial evaluations. Follow-up visits may be conducted via phone.
Get Started in Florida Today
Trimi serves patients across Florida with affordable GLP-1 treatment. Start your online consultation now.
Get Started TodayMore on State Guides
Online Weight Loss Medication in California
California telehealth options for GLP-1.
Online Weight Loss Medication in Texas
Texas access guide for weight loss medications.
Online Weight Loss Medication in Georgia
Georgia telehealth and coverage guide.
GLP-1 Without Insurance 2026
How to access affordable GLP-1 without insurance.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).